TNF and inflammatory bowel disease: Biological drugs mainly targeting the TNF-α signalling pathway or its components have been used clinically and proven to alleviate IBD, such as anti-TNF-α antibodies, but almost one-third of IBD patients showed no improvement and even loss of sustained response over time (6–8).